跳至主要内容
临床试验/NCT01819064
NCT01819064已完成4 期

Do Small Doses of Atropine Cause Bradycardia in Young Children

State University of New York at Buffalo1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Incidence of Bradycardia

研究概览

简要总结

An infants heart rate is very important because it ensures that blood is pumped to all organs in the body. Heart rate may decrease during anesthesia and surgery, and this is why the anesthesiologist will often give a medication to prevent this from happening. The most common drug for this purpose is called atropine. The dose of most drugs given to babies is based upon the baby's weight, but some believe that the dose of atropine should not be less than 0.1mg. However there is no evidence to support this minimum dose. A larger dose of atropine may cause a very fast heart rate instead. Anesthesiologists routinely dose the atropine based upon the baby's weight without regard for a minimum dose.

The purpose of the present study is to measure the heart rate after doses of atropine in neonates and infants who receive less than 0.1 mg.

详细描述

60 infants, ASA physical status I and II, undergoing elective surgical procedures will be enrolled after signed informed parental consent.

All children will be fasted according to institutional guidelines and unpremedicated. After arriving in the operating room, EKG, pulse oximeter and blood pressure monitors will be applied (Datex-Ohmeda Aisys).

Anesthesia will be induced with 66% N2O in O2 and 8% sevoflurane. Respiration will be supported by a properly sized face mask through which he/she is allowed to breath spontaneously. Respiration will continue spontaneously through a facemask at 2 MAC sevoflurane in 66% N2O.

All children will be positioned supine, warmed with a forced air warmer and given 20 ml/kg IV balanced salt solution over 30 minutes after the IV has been established. The end-tidal pCO2 will maintained 35-45 mmHg and oxygen saturation >96%.

After a 22 or 24G IV cannula is inserted, 0.005 mg/kg atropine will be administered intravenously over 5 seconds through a fast-flowing IV and followed by 5 ml of normal saline to flush it in through the IV deadspace. The study (ECG recording) period will extend from 30 seconds before atropine administration to 5 minutes after injection. During this time the heart rate and rhythm (through lead II) will be monitored and recorded continuously using an analogue interface system. EKG will be recorded on paper continuously for the 330 seconds of the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

Observer of ECG rhythm strips was unaware of the study hypothesis, the study drug administered, the dose given and the arrhythmias sought. Your statement that masking a single outcome implies a multi-arm study precludes a panoramic perspective of clinical research study designs and scenarios in which assessors may be effectively blinded.

入排标准

年龄范围
1 Day 至 2 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age : 0-2 years old
  • Weight : less than the 95th percentile for age and height ( no more than 15kg )
  • ASA classification : I-II
  • Meets the hospital and department of anesthesiology guidelines with respect to peri-operative care

排除标准

  • History of heart disease
  • Any condition predisposing to arrhythmia
  • Any medication known to influence the heart rate
  • Child taking anti-cholinergic medication routinely
  • The use of succinylcholine anticipated (will cause bradycardia)
  • Rapid sequence intubation is required (due to aspiration risk)
  • Known difficult airway (may be difficult to bag mask ventilate)

研究组 & 干预措施

Infants and children less than 15Kg.

Experimental

This group consists of children who are ASA physical status I and II, less than 2 years of age and scheduled for elective surgical procedure and weigh less than 15Kg will receive atropine 5 mcg/kg IV during sevoflurane anesthesia.

干预措施: Atropine (Drug)

结局指标

主要结局

Incidence of Bradycardia

时间窗: five minutes

incidence of bradycardia or other arrhythmias

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jerrold Lerman

Clinical Professor of Anesthesiology

State University of New York at Buffalo

研究点 (1)

Loading locations...

相似试验

Heart Rate Response to Atropine Doses Less Than... | 临床试验